Beyond Air XAIR
NASDAQ XAIR
$5.04 -0.11 (-2.14%)
At close: Aug 21, 2026 · 4:00 PM EDT

Beyond Air (XAIR) Return on Invested Capital (2017)

Beyond Air (XAIR) posted Return on Invested Capital of 0.88% for Q4 2017, up 210.46% sequentially from 0.79% in Q3 2017.

Beyond Air (XAIR) Return on Invested Capital (2017) Analysis & Trends

Beyond Air has reported Return on Invested Capital for 1 years, with the latest figure at 0.88% in Q4 2017.

  • Quarterly Return on Invested Capital changed N/A year-over-year to 0.88% in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 0.88% (changed N/A YoY) and the FY2026 annual result came in at 0.45%, changed N/A from the prior year.
  • Return on Invested Capital advanced to 0.88% in Q4 2017 per XAIR's latest filing, from 0.79% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.88% in Q4 2017 and troughed at 0.79% in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 0.01%
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 0.01%
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 0.01%
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 0.00%
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 0.01%
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 0.00%
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 0.04%
10 Beyond Air 3.61 Mn -7.30 Mn 225,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2017 0.88%
Sep 30, 2017 -0.79%
Jun 30, 2017 -0.04%
Mar 31, 2017 0.41%